F. Blasi (Milan, Italy), N. Siafakas (Heraklion (Crete), Greece)
Late Breaking Abstract - Etiology of nosocomial pneumonia in multidisciplinary hospital
A. Petrov (M, Russian Federation), W. Quintana (M, Russian Federation), P. Mosquera (M, Russian Federation), S. Rachina (M, Russian Federation), Z. Kobalava (M, Russian Federation), T. Dmitrova (M, Russian Federation), Y. Yanovich (M, Russian Federation), L. Ezhova (M, Russian Federation)
|  |
Management of complex pleural space infections: As the pendulum swings
A. Jackson (Seattle, United States of America), J. Rayburn (Seattle, United States of America), C. Fuller (Seattle, United States of America), C. Wilshire (Seattle, United States of America), C. Gilbert (Seattle, United States of America), B. Louie (Seattle, United States of America), R. Aye (Seattle, United States of America), E. Vallières (Seattle, United States of America), A. Farivar (Seattle, United States of America), A. Bograd (Seattle, United States of America), J. Gorden (Seattle, United States of America)
|   |
Bedside Ultrasound and Pigtail Catheters for Management of Pleural Effusion in Geriatric Population
B. Svirsky (Naharya, Israel), E. Altman (Naharya, Israel), S. Azzam (Naharya, Israel), A. Samokhvalov (Naharya, Israel), R. Makhoul (Naharya, Israel), E. Kaykov (Naharya, Israel)
|  |
Efficacy of a multiplex bacterial PCR in identifying pathogens in pleural empyema
L. Franchetti (Basel, Switzerland), D. Schumann (Basel, Switzerland), M. Tamm (Basel, Switzerland), K. Jahn (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Digital airflow measurement early in treatment course for spontaneous pneumothorax predicting surgical referral
R. Hallifax (Oxford, United Kingdom), M. Laskawiec (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |
Different approaches of chest drainage in the management of the primary spontaneous pneumothoraces.
N. Carnot (Toulouse, France), M. Dupuis (Toulouse, France), S. Pontier (Toulouse, France), F. Laborde (Toulouse, France), L. Brouchet (Toulouse, France), A. Didier (Toulouse, France)
| |
Spontaneous pneumothorax – 5 years review
M. Freitas Ferreira Araújo (Braga, Portugal), F. Aguiar (Braga, Portugal), R. Pereira (Braga, Portugal), J. Lages (Braga, Portugal), A. Vieira (Braga, Portugal), L. Ferreira (Braga, Portugal), J. Cunha (Braga, Portugal)
| |
Alpha1-antitrypsin deficiency in primary spontaneous pneumothorax
E. Ferreira Da Eira Marques Dias (Coimbra, Portugal), A. Costa (Coimbra, Portugal), L. Santos (Coimbra, Portugal)
| |
The use of antiviral drug Ribavirin in cases of viral-bacterial community acquired pneumonia
M. Kharitonov (Saint-Petersburg, Russian Federation), A. Nikolayev (Saint-Petersburg, Russian Federation), M. Zhurkin (Saint-Petersburg, Russian Federation), V. Ivanov (Saint-Petersburg, Russian Federation), Y. Rudakov (Saint-Petersburg, Russian Federation)
| |
Phagocytic ability of granulocytes and monocytes in elderly patients with community acquired pneumonia
E. Torun Parmaksiz ( Istanbul, Turkey), A. I?nal ( Istanbul, Turkey), B. Çaglayan ( Istanbul, Turkey), C. Dogan ( Istanbul, Turkey), A. Fidan ( Istanbul, Turkey), N. Kiral ( Istanbul, Turkey), S. Cömert ( Istanbul, Turkey)
| |
Risk factors for early onset severe community-acquired pneumonia complications
V. Averjanovaite (Vilnius, Lithuania), R. Saikalyte (Vilnius, Lithuania), G. Cincileviciute (Vilnius, Lithuania), G. Kucinskaite (Vilnius, Lithuania), D. Maciulyte (Vilnius, Lithuania), A. Kontrimas (Vilnius, Lithuania), V. Maksimaityte (Vilnius, Lithuania), R. Zablockis (Vilnius, Lithuania), E. Danila (Vilnius, Lithuania)
| |
The utility of CURB-65 scoring in the acute management of radiologically proven pneumonia
P. Mallisetty (Walsall, United Kingdom), T. Raja (Walsall, United Kingdom), H. Tariq (Walsall, United Kingdom), J. Biggs (Walsall, United Kingdom), T. Balram (Walsall, United Kingdom), A. Castle (Walsall, United Kingdom), D. Dogar (Walsall, United Kingdom), A. Livesey (Birmingham, United Kingdom), B. Chakraborty (Birmingham, United Kingdom), R. Mukherjee (Birmingham, United Kingdom)
| |
Influence the phosphatidylcholine treatment program on surfactant protein D levels in hypertensive patients with community-acquired pneumonia
O. Shtepa (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine)
| |
Antibiotic treatment in community and hospital acquired pneumonia complicated by Clostridium difficile infection.
k. zycinska (Warsaw, Poland)
| |
Comparative laboratory evaluation of systemic inflammatory respond in patients with opium drugaddiction and community-acquired pneumonia
O. Viltsaniuk (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine), A. Hunko (Vinnytsya, Ukraine)
| |
Incidence and predictors of QT interval prolongation in the intensive care units of a tertiary pulmonary center
Z. Hosseinpoor (Tehran, Islamic Republic of Iran), B. Farzanegan (Tehran, Islamic Republic of Iran), S. Seyyedi (Tehran, Islamic Republic of Iran), M. Rajabi (Tehran, Islamic Republic of Iran), H. Emami (Tehran, Islamic Republic of Iran), S. Baniasadi (Tehran, Islamic Republic of Iran)
| |
Evaluation of a bespoke and innovative model of care to reduce emergency admissions for community acquired pneumonia.
O. Hampson (Liverpool, United Kingdom), E. Rickards (Liverpool, United Kingdom), D. Wat (Liverpool, United Kingdom), S. Sibley (Liverpool, United Kingdom)
| |
Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia (BPD)
P. Um-Bergström (Stockholm, Sweden), J. Hallberg (Stockholm , Sweden), M. Pourbazargan (Stockholm , Sweden), E. Berggren-Broström (Stockholm , Sweden), G. Ferrara (Stockholm , Sweden), M. Eriksson (Stockholm , Sweden), S. Nyrén (Stockholm , Sweden), G. Lilja (Stockholm , Sweden), A. Lindén (Stockholm , Sweden), Å. Wheelock (Stockholm , Sweden), E. Melén (Stockholm , Sweden), M. Sköld (Stockholm , Sweden)
| |